TNFSF10 and breast cancer: Apo2 ligand (Apo2L/TRAIL) is a member of the tumour necrosis factor (TNF)-cytokine family that can induce apoptosis in a variety of transformed cells, including breast cancer, whilst sparing most non-transformed cells [10]–[12].